Ellis Hospital

Schenectady, New York 12309

3 studies enrolling now · 8 studies all time

What they study most

Acute Ischemic Stroke, Cancer, Carcinoma, Non-Small-Cell Lung, Cerebrovascular Accident, Fever, Heart Failure, Percutaneous Coronary Intervention, Remote Patient Monitoring, SARS-CoV2 Infection

Studies at this site

• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) — Recruiting now
• Remote Temperature Monitoring of Patients At Risk for Developing Fever — Recruiting now
• Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment — Running, not enrolling
• Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure — Completed
• Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) — APPROVED_FOR_MARKETING
• A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator) — Completed
• A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients — Completed